Recent BFLY transcripts
Associated BFLY filings
Todd Fruchterman | President and Chief Executive Officer |
Stephanie Fielding | Chief Financial Officer |
Agnes Lee | Vice President, Investor Relations |
Matt Taylor | UBS |
Josh Jennings | Cowen |
Good morning. My name is Emma and I will be the conference operator today. At this time, I would like to welcome everyone to the Butterfly Network Q3 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. you. Thank Instruction] [Operator may conference. you begin Lee, your Agnes
and and Good Earlier financial this thank earnings you presentation, XXth results release a Company's this update. us use non-GAAP today. Chief for joining of Officer, Fruchterman, XXXX, September morning, the ended Investors on of are currently financial the measures, available which Stephanie Todd and quarter, morning compared a and third Officer, business will The Dr. to and of Executive for the website the which Fielding, most Butterfly's Financial provided ir.butterflynetwork.com. reconciliation Butterfly President management's include applicable morning's GAAP has released measures, Chief at section Butterfly's call. host
subject information, of forward-looking statements current business. the our expectations a assumptions, of Commission. and change These risks and financial may Exchange uncertainties COVID-XX to that on regarding, based may anticipated our with include potential The described approvals, and in impact things, materially that to business the made expectations involve business. call, services, of effects our or from are results, regulatory markets products pandemic on current other are number to potential financial other statements certain and today's During will the and combination statements and differ be on These cause Securities among the impacts, and respect are we results of performance, and potential services forward-looking making future our actual those risks and development and contained future statements. of the size in These other with growth forward-looking products statements. for filings
to the any undue to these reliance not forward-looking obligation statements; cautioned Company and such on are statements. place disclaims update You
reconciliations with are intended gross call, we accordance considered EBITDA. and to financial not measures in adjusted isolation, These in most Principles profit, GAAP of and prepared financial adjusted of adjusted substitute financial this results margin, which and the not today's prepared financial are The measures release including financial end non-GAAP at Generally financial in definitions why presentation. a or will GAAP. we comparable of U.S. Accepted the non-GAAP these the measures, the non-GAAP in is and press included are These discussion During measures accordance gross Accounting to with these present measures, measures, non-GAAP slide refer GAAP. directly be
dialed yourself. call call. the you've website the replay and and reminder, website please available Because our section slide be the Dr. a if access is event the in a with would the call the Events in I will the webcast to the recorded, we use conjunction from a over visit by presentation webcast for this To the like and advance video a slides and there of our solidly telephone, or being As remarks. from now section to in download audio being in Investors will shown both for the presentation audio either be and live in telephone experience, delay between on was the content, turn live short please webcast, Fruchterman the of referencing best our webcast, the
revenue our of day for based transforming democratizing are year. upon the improving the build progress by medical be expectations of our proud most morning, you, while and advancements more of to the enabling as and clinical make team vision There our time imaging towards learn must to good our care strength taking this the We for balance us Thank current every reset environment, experiences you appreciate recent And realizing decision-making. foundational much and everyone. and healthcare informed we Agnes, we and for is our of join we quarter.
QX for grew revenues While our % XX year-over-year.
are %. achieve user hold and to and represents in the of to there To our and annual % and just logistical with necessary early practitioners work, commercial about one-year We the I feedback. nurse, the important of recognize practice. increasingly broad current layers of of information are advocacy, challenges, have affordability, year it the XX and in May technology of understanding Butterfly adoption, joined provided our respective life-saving, had by practice of how base, We improve good conditions that their fatigue Butterfly, deep doctors both technician progress healthcare care excited of and power into by to to growth integrate F portability, revenue them engaged we multiple group in their across of expect Butterfly and about understand specialties guidance utility. is and is activities, areas enthusiasm this is and adopting in by Many medical ago user accelerate our range decision-making early Butterfly and Company. breadth This delivery. with multiple XX COVID me offset second users. and Many been altering properly individual segment, management prior enhance a its are XXXX, of educate now short Butterfly we the doctor, full-year but can mounting users consequences. having A of appreciate reaffirmed as concurrent what's falling Or
and to on rapidly helping users specific their it of capabilities Here, we practices system into focusing and workflows. are incorporate this
the use out around Over will aligning quarters, coming energies so. specific our programs continue commercial targeted cases, specialties and doing procedural we and roll at to
unique systems. the to increasingly we integrated of because well-positioned Finally, engage are of group of Butterfly, third health a large, aspects users,
the for care. of many Our value proposition sites across wide divisions, and enterprise user departments, reaches
and enterprise can new cost-effectively and insights clinical data scale. conveniently, we at alone integrate As
of ease-of-use personal systems work from sales about doctors, and support has recognize drive that North partnerships. and that health technicians, Introducing nurses, early the all more security, a XXXX and in workflows projections in Butterfly commercialization, effectively require they me proper close together X as aggressive our ensure integrity, hospitals And optimize treatment Such persistently will enterprise thread management iterative. to less be them and and and and One settings. We will a simplicity development, about commitment pleased unlock transform all clinical clear we are evolution in are change we note and all to value and more ramp. It's diagnosis customer journey be market, be that our among geographies, journey there consistently this in do been way simplicity. to customers we differentiator momentum expect clear audience. as commitment and is to is collaborative clinical systems Across is in our and need variety our current of medicine. course Star back-half of advancement our our and our that permeates to important we team is of to of fundamentally that layers for with we made compliance, journey, a enterprise Delivering to a and an since practice ease-of-use information the patients practically were valuable care integration billing and enterprise continuity. will that we first with cycles user all a help significant the from important included the to engagements lanes
approach led rapidly Company and and more have to market integrated to need to health commercial strategy to specialties. a to reoriented adjust a the approach overall shift the team systems While direct-to-user we from
do. believe of will With in give as this rapidly its only [Indiscernible] however, XXXX integration lagging a Butterfly, clinical specifically overall of we level influenced uniquely augment resulting to in during who on in their developed revenues the On the Butterfly to will maximize wave, QX suffering and to affordably. enhance from constraints QX opportunities optimism more system great quality to has practice have are building, and been those is evident engagement the implement times, more supporting that technology needs than net time [Indiscernible] are professionals our learn, developed just be rapidly, as innovative deploying and it leadership effectively, long-term reflects shortages. seen well [Indiscernible] deliver by To satisfaction, about macro with and of not one as commitment and solutions well-positioned the medical in-process is a implementations, ability it prospects to ease well our times discussions promoters These of constructively human very COVID market, level, to have Our pressing our that in future we and rather scores, its focusing transitory but Butterfly for customer is exhaustion evolve it, our alike acceleration. severe near-term the business value institutions and information our of while is factors. of sequential in collaborate, a Butterfly understood strengthened enterprise community unprecedented performance of and that is competitive talent recent and which [Indiscernible] kick-start with beyond, these customers to to approach, QX have many and more at in needed. QX. at their listen, to Delta -- of have our are All commitment changes from labor treat the and and indicator the respond these scale. challenges healthcare diagnose confluence Butterfly advantage, better that customer the issues solution The support change new which behavior solution large team and positioned are these transitory was uptick described. believe most resource the progress ease-of-use. we the I clinical expand is of flotation and negatively We that We shift prospect that improving and further attention factors to me the create, commercial Amidst utility amazing
technology falls differentiated Butterfly, information decision-making that The to of is Our has made, goal, in expensive the care obtainable and change a to practical, decisions power capability affordable, medical a is goal and Butterfly an more way. larger, way societal with million and important care the leaders. but aspiration. more Butterfly, accuracy, commercial and patient $XXX it experience and one gathered, impact maximum delivered. and was and public simply of are inform and not be collaboration fundamentally outcomes, our and short for planning cost-effective than technology is goal subsequent bringing unmatched of An of course professionals treatment, provide more setting. and the obtaining care can connectivity frontline clinicians diagnosis, would With is an healthcare that dramatically of understanding and created with funding the through improve regardless Butterfly component better speed, replace industry-thought
barriers vision our commitment not and speed quarters, Butterfly a coming with you And the dramatically change. our development is and reflective we we the optimize that will platform the members -- have undertaking, and implementation our an care who workflow is priorities. of enablement device deploying our solution Group the we is in And around only at and This perpetual is demonstrative our in back to understand Stoica, or scale onto enhancing who advanced to of include our beginning of are a institutions our continue build assessment We team, our level, to of share the co-development firm journey the the by education component journey, take us. requires see the go-to-market board at have user the facilitate leadership that of of practice see level, approach. have to to team to why enterprise and [Indiscernible] Whether software the critical these assembled removing for with agility but Andrei is in leadership You throughout practices This our in improve critical. collaborations. committed, more of investment Technology as of standard under industry-leading iterative reoriented the CTO of we it the an enterprise And tool to Institute and of further bring larger best scale months, and support AI. system. behavior burden matter joined only
a drive the expensive [Indiscernible] our augmented and sound conversations clinical have pave as Dr. clinical [Indiscernible] means information leadership evolution clinical for to of to advance the under workflows. We direction into in
Despite you have more caption agreement We internal in Stacey which the [Indiscernible] the revamped full the continue in products, our The to expansion. But to projected investment [Indiscernible] revenue moving officer capture with the complemented also and revenue and the progress the with of full engaged discuss to our give more stream plan are an organization commercial to us in in positioned in better original aggressively Pugh of making AI to our adjusted we we invest call. exceed capital see progress our half and and gross our XXXX. we Butterfly investment necessary of back [Indiscernible] I EBITDA shortfall, later the potential deeply forward. people, exclusive evidence will detail sales and community margin, significant human believe are adjusted our cannot in
Our [Indiscernible] indicate see release underlying to we concurrent revenue investment the our forecast to investor complete QX in accelerating call. XXXX earnings and expect is building momentum XXXX our growth with community and
you rate will of confident we However, we'll projected share XXXX our today I that for exceed with revenue are growth growth our that XXXX, full-year rate.
and made forward. and our significant have sprinting XXXX team We is headway measurable in
like channels, and specialties across on that public with management board a Butterfly to Dr. high-quality had support leadership within highly breadth a have also that the the had Coast partner, uniform in building We co-create few anywhere. Swartz. starts sites on Officer Dr. with quarter. appointment from all true to know a growth. health our access Dr. our will Guard, our and roles. conviction vision oversight geographies with that deployment to we in alternative and then healthcare the led country's as COVID-XX and in U.S. never the years and Erica to for updates of the the brings of superior version traditional and serving with of we imaging growth she of She Company, growth capable and medical that where strategy, From I'd healthcare collaborate, Butterfly. build this timely enable innovation public technology XX and Swartz team service image share and care, We here Swartz versus everywhere As support Medical to data and [Indiscernible] leadership our To Dr. other formed commitment are never have a assessment Chief before, capture expanded home, will of across imaging. pandemic. response serve spent success Roth. aspects information every committee our talented, newly
Troy supporting Vice initiatives For the we third quarter, have and our and business oversight this. of been leadership adding and the had Adelman Dr. executive Regulatory to providing and Digi OraSure roles at post-market Johnson, Senior In and the of Focus as Becton accomplish previously our business, as Affairs, Compliance, Regulatory FDA brings and Quality, bioMerieux. and experience He over XX Dickinson, teams. years & to scale we Technologies, a role expand we a surveillance President Roche, on Industry Quality. held Quander Troy, continue of and Johnson with Olympus,
Recently, Troy Butterfly to [Indiscernible] team leadership I With existing timely rapid The regulatory that we even of phases affordable growing an talked that are more and care. to the use have effectively being about physicians of article by that adoption encouraged the New the and Troy, the of happy with bring and quality have am stronger our and very the broader driven evolution and to additional POCUS market of and become through Medicine published addition of We of our compliant -- confidence in machines, also radiology a evidence a practice. demonstrate addition ultrasound background us of strengthened our further England with factors team, to advent smaller, combined fashion. without the of part growing the the find Butterfly's with by led next in and take ability Journal
then FDA -- solution a told from showed there has changes to is CMS first exclusive NTAP from anesthesia anesthetic. the variety Ultrasound who possible. we can so the pain. creates come with by and recent innovate accessible of regional only There And Beyond a patient challenging that add-on it information powered our during quick change the partnership surgery. burden safely administer like on ' and extensive He specifically, solution, is Captions and [Indiscernible] One pharmaceutical and and August, the the take improve relevant of an more also payment but the Biosciences This solution customers is Butterfly our Pacira practitioners Anesthesiologists using Butterfly with investors specialty area, pocket XX is with that to and we of considerable recent Day. as providing that, software. procedural academic complications. is conditions, and there in I the will more at a disruptive significant through Butterfly regional of of Butterfly more care targeted a without more our a Viz our publications, would practices meet to technology recognition. leading are of to a what stories cardiac integrated capturing Pacira to not occasion anesthesia undetected of In interpreting therapeutics timeline only is and while state. Needle Important physicians just present Even that about office. institutions. -- a technology that are Not only in see Health, and With Investor a the needs makes administer the presented recipient, being identified across and post-operative an cardiac disease and manage adoption ease-of-use. enabled their or AI Butterfly communities. anesthesiologist spanning picture there behavior highlight training, recovery. the Butterfly ultrasound was enabler anesthesia Company in announced is as areas of but is not with technology Caption of broader
sicker, like from maybe care potential failure Caption, acute with symptoms therapy the bring fewer one the in showed, failure IQ heart unnecessary patients people medical introduce that Information [Indiscernible]. and and previous months. diagnosed primary visits bring circulation have earlier failure through XX to care unlocking + solutions, failure As on to X during decreased We cost. the heart resulting Butterfly in visits of Needle [Indiscernible] advanced get is recent heart acute before new to combined clinics they to in the able care expected market are study heart % a diagnostic sooner settings identify the we'll believe platform help undiagnosed Viz and markets.
a as Butterfly Company, global for become evolve we greater the will As demand a growth everywhere. expansion as focus
excited our in a growth mechanism continued distributor expand reach. our the relationships; to to are of share We key momentum
quarter, partnerships I'm recall the that Kong our True medical. we mission care into quarter the that pleased entered shared through will region Hong this democratize world last entry to our You to into around recent we strategic and and will available Abdul with we we more Turkey, partnership Pakistan, Jameel to through Butterfly Butterfly make North in Middle India. a bring Africa, Chile, and will Latif Health, East, the
tools, outcomes With we Butterfly these is activities, They care healthcare with the area and are that be and in to workers not this markets otherwise mothers. solutions, will last Gestational are devices to information advanced aid creating about Butterfly is to access. needs address that mothers be quarter. our just not will access pregnant launched governments introducing to available. equity affordability, unique the need take more focus provincial Age Veritas and improving the portability, for One the as global clinical into health provide we calculator health care. better, Leveraging Butterfly such for just helping homes partnering to to capabilities And including that expectant new by on of OB and technology Pakistan the that of partner
growth of driver our organic Another innovation. important is
with ultrasound product % settings. for and viz Doppler was is IQ and with easier probe maneuvering. the a smaller clinical launched We our use face of designed The and % new Vet to to second-generation probe shorter tool, more a released IQ Butterfly device veterinarians color we new Vet, many market. and bring Comes for XX variety valuable sensitivity, a veterinary information XX which designed quarter, features. in capabilities veterinary This needle overall notably, a a have + +
with relationships we now + U.S. in in very With to our Vet, purchase the We're human international IQ value the in grow parallel continue work market our excited is expanded have the markets. UK. to introduction in also of bring now and to veterinary the market we The XX for product And new reach. healthcare. available
vet had their use that veterinary scale large A would change This Additionally, several worked we of ultrasound long reflects to reported she a Butterfly differences dog rare by performed a traditional a deployment hospitals. partnership of veterinarian the announced as in Butterfly perform rare ultrasound Butterfly used with of breed to different physical use for The share [Indiscernible] across spleen experiences hospitals. sonographic needle one bring for them. to liver and their This both disease. aspirates, vet all which the which from Butterfly veterinary with fine and catalyzed important to is lesions decision veterinarian I Rare vet at exam in to medicine. led the a to perform their noticed an adoption the diagnosis the the tumor. to and hospital to quick, owner. breed you. metastatic that like quick then where instance The to with was a look due ultrasound a with breed Butterfly between There's adopt mark that perception
associated Rather yet All appointment. waiting insights another this to possible. provide specialist, the was immediately with makes acquire out obtain guide occurred flavor by and an of a owner, the during to to stress pet to veterinarian for information waiting accurate the information reducing valuable Butterfly one diagnosis of what to able referring than
of more Butterfly that informed practical, great detailed confluence is the transformational way. understanding information to to a acquisition the that potential a enabling software of information enables turn in device and points I cost-effective information a power differentiated that ultrasound a crucial innovative that to usable. carrier decisions. Before by The unlocks of think makes for Through want [Indiscernible] financial is our I discussion, over direction. reiterate I re-imagine Stephanie Butterfly's, it healthcare to number more are
hard changing work drive an this change. experience. know new clinical are and now behavior creating We well-positioned are we entirely positive we to And requires
build that broadest number we sonographers. practitioner’s clinician. and make are want clinicians ease-of-use relentlessly proof will continuing of [Indiscernible] We points enable used guide We review want environment, I to to and of [Indiscernible] don't pursue better grown Butterfly in my challenges just our in to demand of a locations results. better still use Butterfly. with have only to continue we setting. strong simplicity the a or Butterfly see Even months turn procedure. And ultrasound to We for momentum X to financial make [Indiscernible] to to seeing of will the acknowledge to the are the current stronger. and finally, be Stephanie
Thank you, and Todd, good everyone. morning,
in grew quarter to XX Third revenues XX.X%. margin came gross year-over-year an at % adjusted million, $XX.X
While that revenue an healthy, revenue these for in main Product they of necessary $X.X numbers compared the same did fulfilled meet revenue sales quarter original in driver in our from $XX.X is product XX.X% XXXX, are traction fall of by Units XXXX. short projections. X,XXX the increasing in ramp was Growth an the best were was direct driven of QX X,XXX our %. force, to increase increase period with in performance XX in the the back-half our quarter, million, million from business.
focus On sales We related slowed Chile partially reflection from our And abated. more are believe of the combination we in $X,XXX. the relationships resulting to pricing distributor a quarter of validates Butterfly to increased direct-to-user and offset New users. Pakistan our August. labor sales direct-to-user of the outreach a during short-term the individual a that seeing IQ early to with adopter curve. and And we this time reaction we expanded + is COVID which individual shortages professional on the end to to also health It patterns believe due surges due price believe and we a the [Indiscernible] we note, direct-to-user anticipated. actions tailored by audience is that quarter, institution. a And and attention what in
offer during introduced are any not promotions trends season, we acceleration holiday any when modeling in no QX, significant did have +. the our we price XXXX normal plans IQ QX. other in we And patterns in than direct-to-user as Butterfly buying to We hardware the
revenue education. and commercial users We approximately through supporting and continue million Subscription XXXX. in our million our in quarter, growing targeting engagement from by third by specialty, XXX to website, a their activities, was enhance the $X.X customer % prospect QX expanding $X.X
a subscription-based, XX our as of Our subscription XXXX, is point was which XX recognized revenue compared of define % total mix, % in periods quarter the as in increase. we with % that and XX percentage third reporting
end now to gross in margin. was presentation. the from and in of the to profit XXXX QX gross calculations $X.X found to XXXX Reconciliation profit Turning compared adjusted gross Adjusted press GAAP adjusted Excluded and million gross today's be profit $X.X negative slide release at adjusted QX million is can of from vendor. Based current profit adjusted with may inventory reserve taking QX not commitment able no a use. our manufacturing on we There third-party the is gross non-recurring impact be on million $XX.X that loss we estimates, purchase a our in adjustment. are XXXX this a cash on to
In addition, such an uncertain environment is an advantage to our demand.
operations to an for care, the $XX.X from spend in are which $XX the the public adjusted quarter on up and as and a for adjusted by capitalize team XX.X% million, year-to-date, -XX.X% QX we to the well the QX transform in during in increase are an a $XX.X $XX.X the XXXX, of XXX to as of QX XXXX, was XXXX gross expenses, negative -XX.X% third was third of opportunities as quarters we the the offset our making was and of as prior three to companies, XXXX. compares innovation of first million by significant driven margin loss margin year. of XX.X% million operating to which the grow leverage we to XXXX, and was Company net increase of compared financial position. gross Our for quarter [Indiscernible] a Loss our or in operating both improvement see compared environment and million decrease in build-out % loss primarily in expenses to investments for primarily the from of million due a of in $XX.X Net higher QX million gross Operating XXXX. investments XXXX, $XX.X margin. constrained XXXX
our Adjusted of with due $XX.X million liabilities, was Adjusted today's of not loss a exist Our EBITDA of reconciliation, by XXXX. warrant in change period in loss impacted the million loss press same positively the non-operating $XX was a gain release. a value fair XXXX. $XX.X to compared in EBITDA did net which in million
Moving to our capital resources.
We have our continue position allows a journey. cash strong in investing to us that
September equivalents the from $XXX.X marketable million from second quarter purchase Sheet Balance cash a million million. [Indiscernible] which of $XX.X cash As liability. the reclassification $XX.X the XXth, XXXX, reported our XXXX, and decrease were commitment quarter of securities was to in and
of and the materials theme discussed reliability older against and upgrading continued trends commitments. our position purchases. for of direct-to-user to in reduction which in help determined light obsolete. we have we raw the reclassified subject implementations to have This cycle from offset inventory the that and purchase our we're In longer the adoption partially seeing to material on million has additional delayed was development by raw increase healthcare, older inventory. in material raw call, system decrease Todd backdrop COVID the including is earlier we purchases and $XX a to -- product Consequently, As minimum that sales institutions, reserve a of of on technology, transformational likely us inventory systems related future
ramp our % pace projected adjusted of views XX is to to [Indiscernible] revenue our gross % year and approximately $XX performance adjusting slower be $XX guidance. are the XXXX To XX in or expenses. margin and reflect XXXX, current We million on total our to growth consistent
assuming guidance these have and million %, warrants. to XX financial loss will % expected $XXX for adjusted %, it full-year Gross to result, now our be EBITDA gross $XX for $XX to we million XX net trends margin And gross is to of to I $XXX expected to be is our a no As with and to summary adjusted XX be Todd that, value in change fair and also margin adjusted Adjusted expected XX negative million, EBITDA. the % over is margin million. expected to be is updated back comments. in turn to
in quarter Stephanie. earnings mission for our like team the you, you And thank XXXX Butterfly's also thank QX. to and for progress participating excellent to Thank call. dedication in their all we have would Butterfly third the made I
the indispensable at what's our you From your and teams behavior and scale. our time ongoing its And our imaging One journey to even as position U.S. on upon deliver to to momentum truly and care as our an medical well forward innovation globally, ongoing empower are everywhere. Thank across to expansion clinical changing to updates We beyond. Butterfly in Space-X I individual tool is providing for look of and that and unique we practitioners anywhere in healthcare. democratize today. mission capability
the turn now questions. call will for We over
Josh Josh Your My the of from Cowen. apologies. (ph) from from question UBS. Matt comes first Taylor line Jennings Earthwright --
line open. Your is
Thanks morning. wondering about I for you for maybe sense just market give question. Good share this talk overall could on within the just Okay have us that you is maybe you what views was is growing taking backdrop. and market that your updated if the thanks. purchase a the any think
Hi, Matt. Good morning. the Thanks question. for
the any on I our occurred that that think circumstances have with incredibly believe is we given we perspective opportunity opportunity don't changed of I solution this say continue large, PAM versatility the the to quarter. have. the has the that that for (ph)
continue of nothing we and excited opportunity there Journal reactions those the perspective the what But short and see (ph) and market. the market us the term of signs cited give PAM we seeing that that adjusted New Medicine, are is types indications continue and the responding to We we're on of confidence about in our continue about that's the England to the be excitement size to
Butterfly is, not and is excited right be I now. think [Indiscernible] continue Matt, on evolving thing about while the and very opportunity, traditional we other to the working
the also that's And tool look that person it as attributes, to to you a adjustment current and leverage Butterfly's So are an can and a we allows clinical with decision-making. around and its market tool TAM advanced as lot a it workflow tool, in of around all in considered an those POCUS, thinking. leveraging clinical workflows use it's at capabilities, ultrasound information into bring as informing assessment the
can Butterfly see capabilities. we -- POCUS of its current affordability, ham So with the portability, flash do its the opportunity POCUS what its at and because
Your Cowen. comes Josh the with question from line next Jennings of
open. Your line is
for Thanks taking the morning. Good questions. Hi.
Josh. morning, Good
and Todd little about driving QX morning. the that in what's and hoping ask the outlook lagging to QX about understanding indicator, in a and is talking the results Stephanie. the bit to I optimism was Good more evolved it's outlook indicators -- to if assuming learn not for than just momentum and you're XQ and channel, any they've was the adjust be call I'm risk of business. a since follow-up how enterprise there the the maybe leading allowed to and key the disconnected. getting and
or all and should for we maybe outlook, about XXXX questions. any move XXXX just months. taking expect that any as through then next that the wanted pipeline you drive we XX updates be other Thanks to action XXXX for thinking the Just
right. All
So to to try that. going thanks, Josh. I'm unpack
I you me start, then it let if and can So capture don't follow up. all,
and things saying a about first, yet. think start about not lot is I me happening, by more happening So this things not let less
so, of in positive really behavior care conversations And change evolution. signals. is a This seeing lot and we're -- around
optimism not in solution, workflows differently that think functions integral way different we're the not just and driven but -- institutional lot to about the So an by as conversations level is within as aspects our Butterfly, a in larger having hospital. about focused the different incorporating as
that's of lot our a driving optimism. So
As device of When across as here. think information probe, advantages marketed a the chip that it we a ultrasound And about it on care. came advance. we a provide ultrasound and evolution when to technological of body continuum came was market, single the Butterfly to the our a was that was lot of at about, Butterfly ultrasound how looking think market, real whole we are
it I into think market. the introduce was a to that great way
perspective, to much we go and an we a Butterfly specialty can institutional and As much approach targeted more How more XXXX, incorporate both users. And are the a from into a seamlessly you workflow into connected but practice. approach into perspective. and more taking from
people more So absorb approach and we're taking workflow. we're and helping a specialty that behavior into the change
like Butterfly it. is with getting for getting it's to when you doing something people that case, using it. the that's with now people expand and focusing specific then entered to on it So what And people we've by haven't And very get market, use adopting how when can had, value getting made of new it's started much technologies. and we're it it available people a comfortable you lot about new
can with the information that itself device the from then and workflows. acquire can into the you how make information it so we and And incorporate
more we're to the workflow. to We're specialty So a more help utilization, partnered much with and focused taking taking people approach incorporated with is a going more be much into approach practices enterprises institutional realization you much about in one it, about think POCUS, can't differently when if medicine institutions. entire the co-development think true practiced in traditional versus And value for That's be really another. about building approach. you across anymore their
positive that as so really for delivering alternate -- workflow we we -- should or channels think more are our you that, that. I are high decision-making maybe early about journey -- sites going of and a evolving And as then are a is of the we're about helping that the to that outside level journey and as across until hospital generating care. excitement Butterfly. you of being you be information the real information Great. technology our of And realistic about the you in Thank journey of is the a a care contributors our tried level decisions decisions early make consistency to the that and to super as will international things and more of about how so Josh. more have continuum more think care not be being when of outside we the in mentioned of hospital. things. care then we just excited we to think customers just versus be very as to mean, the channel are and meaningful is as one have have for or from seeing and made XXXX. our Even for being XXXX, build-out hospitals in a certain in ultrasound enter hospital, in too. continuum Absolutely, I those Butterfly be care, getting is elsewhere Company, that moving a machines drive And of see meaningful we indicator but to XXXX advantage and challenge forward much going you just that's We're don't a
good outside XXXX the of we U.S., both care, lot continuum talked how real we to it journey the just across We that a see So optimism to and the across and that continuum. expansion of and you in see we we're thinking see institutions about. of I market the enterprise in geographical developed is and see developing about excitement in a
want mean, for veterinary really see veterinary And differently How exciting. starting people way market that it. and decision-making Butterfly excited human human excitement a Butterfly XXXX. we we're ultrasound that And to is cool are so utilization amount by then And early. your I people think been very market care about the the market thinking that's of same outside we're information really Butterfly into is of about delivery the market. ultrasound tremendous and in approach getting in the do of what's we in the you and about incorporating
generating So XXXX. avenues in really in growth we're about excited multiple
technology board. kicking of is guess later NTAP detail or And way and of other software coming Then just when integrated on, the adoption terms have any think we we utilization or here, pipeline in that caption that could should timelines, just could one the on did. last platform can again. in catalyze could Great. platform next-generation Any and launch actually stronger occur? I trends. that new catalyze -- then you full updates -- Thanks
situation. and allows broadly doing across available influencing because procedures and onto it that clinical away more bringing the We're been the Caption us the and device Josh on pipe winter. helps market. that readily from decisions about really This ultrasound excited information for I they the information we're it with about thanks. the user and past really burden think and Sure, that to track wasn't we available less just on people about think information taking I really have really and is like and think the the example about because it's that bringing into the where getting differently demonstrate in year, about about than talking care earlier earlier the into and And it's We're -- market in -- launch excited we're said call, we've which Caption decision-making.
excited that. And so about we're
pipeline, in excited in our relates progress to it making. that see creation and as look here. we've where that technology of continues that the with then been said, the teams about; in, And centric. just customer our we're in timely at And has the coming think cadence as winter our releases, out to here we being differentiation very timeframe future. near our like the realigned spoke Andrei see of really The our technical a couple year software I technical enable ultrasound customer normal fashion and and are on hardware teams I And You'll software. the have come very We've development in We're making call. releases us lot the up you'll great coming think then - this was value technology. our across out to in a open close needs progress continuum getting we're evolution about of getting I the
change users that's really of the how ease-of-use, think information generating together, You And helping we're all with to bringing were is really that into taking data clinical about really are starting we're journey accelerate XXXX that lean help clinical the burden, technical it clinical practices. technology helping with the Josh, education, incorporate pieces And device and and more I technical we're take our -- into where our their our our behavioral as organization performing. is leaning growth. and organization for this our and excited
so Thanks much.
questions call. time. This this concludes no are There today's further at conference
now may disconnect. You
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.